Solésence to Join Russell 3000® and Russell 2000® Indexes
Solésence (Nasdaq: SLSN), a healthcare solutions provider specializing in beauty and life science, has announced its upcoming inclusion in both the Russell 3000® and Russell 2000® Indexes, effective June 30, 2025. This milestone follows the company's recent Nasdaq uplisting and is part of the 2025 Russell indexes reconstitution.
The inclusion is based on FTSE Russell's objective market-capitalization rankings, which capture the 4,000 largest US stocks as of April 30. This development is particularly significant as approximately $10.6 trillion in assets are benchmarked against Russell US indexes, potentially increasing Solésence's visibility among institutional investors.
Solésence (Nasdaq: SLSN), fornitore di soluzioni sanitarie specializzato in bellezza e scienze della vita, ha annunciato la sua prossima inclusione nei Russell 3000® e Russell 2000® Indexes, a partire dal 30 giugno 2025. Questo traguardo segue la recente quotazione della società al Nasdaq ed è parte della ristrutturazione degli indici Russell del 2025.
L'inclusione si basa sulle classifiche oggettive di capitalizzazione di mercato di FTSE Russell, che considerano le 4.000 azioni statunitensi più grandi al 30 aprile. Questo sviluppo è particolarmente rilevante poiché circa 10,6 trilioni di dollari in asset sono indicizzati agli indici Russell US, aumentando potenzialmente la visibilità di Solésence tra gli investitori istituzionali.
Solésence (Nasdaq: SLSN), proveedor de soluciones de salud especializado en belleza y ciencias de la vida, ha anunciado su próxima inclusión en los índices Russell 3000® y Russell 2000®, efectiva a partir del 30 de junio de 2025. Este hito sigue a la reciente subida de la compañía al Nasdaq y forma parte de la reconstitución de los índices Russell 2025.
La inclusión se basa en las clasificaciones objetivas de capitalización de mercado de FTSE Russell, que capturan las 4,000 acciones estadounidenses más grandes al 30 de abril. Este desarrollo es especialmente significativo ya que aproximadamente 10.6 billones de dólares en activos están referenciados a los índices Russell US, lo que podría aumentar la visibilidad de Solésence entre los inversores institucionales.
Solésence (나스닥: SLSN)는 뷰티 및 생명과학을 전문으로 하는 헬스케어 솔루션 제공업체로, 2025년 6월 30일부터 러셀 3000® 및 러셀 2000® 지수에 포함될 예정임을 발표했습니다. 이번 성과는 회사가 최근 나스닥 상장 승격을 이룬 데 따른 것으로, 2025년 러셀 지수 재구성의 일환입니다.
이번 포함은 4월 30일 기준 미국 최대 4,000개 주식을 포착하는 FTSE 러셀의 객관적 시가총액 순위에 기반합니다. 약 10.6조 달러 규모의 자산이 러셀 미국 지수를 벤치마크로 삼고 있어, 솔레센스가 기관 투자자들 사이에서 인지도를 높일 수 있는 중요한 발전입니다.
Solésence (Nasdaq : SLSN), fournisseur de solutions de santé spécialisé dans la beauté et les sciences de la vie, a annoncé son inclusion prochaine dans les indices Russell 3000® et Russell 2000®, effective à partir du 30 juin 2025. Cette étape fait suite à la récente montée en gamme de la société sur le Nasdaq et s’inscrit dans la reconstitution des indices Russell 2025.
Cette inclusion repose sur les classements objectifs de capitalisation boursière de FTSE Russell, qui couvrent les 4 000 plus grandes actions américaines au 30 avril. Ce développement est particulièrement important car environ 10,6 trillions de dollars d’actifs sont indexés sur les indices Russell US, ce qui pourrait accroître la visibilité de Solésence auprès des investisseurs institutionnels.
Solésence (Nasdaq: SLSN), ein Anbieter von Gesundheitslösungen mit Schwerpunkt auf Schönheit und Lebenswissenschaften, hat seine bevorstehende Aufnahme in die Russell 3000® und Russell 2000® Indizes angekündigt, die ab dem 30. Juni 2025 wirksam wird. Dieser Meilenstein folgt auf das kürzliche Nasdaq-Listing des Unternehmens und ist Teil der Neustrukturierung der Russell-Indizes 2025.
Die Aufnahme basiert auf den objektiven Marktkapitalisierungs-Rankings von FTSE Russell, die die 4.000 größten US-Aktien zum 30. April erfassen. Diese Entwicklung ist besonders bedeutend, da etwa 10,6 Billionen US-Dollar an Vermögenswerten an den Russell US-Indizes ausgerichtet sind, was die Sichtbarkeit von Solésence bei institutionellen Investoren potenziell erhöht.
- Inclusion in Russell 3000® and Russell 2000® Indexes increases institutional investor visibility
- Recent uplisting to Nasdaq demonstrates company growth trajectory
- Access to $10.6 trillion in benchmarked assets could improve trading liquidity
- Automatic inclusion in appropriate growth and value style indexes
- None.
Insights
Solésence's Russell index inclusion increases institutional visibility and potential liquidity, following their Nasdaq uplisting—a positive market structure development.
Solésence's forthcoming addition to the Russell 3000® and Russell 2000® Indexes represents a significant milestone in the company's capital markets evolution. This development, effective June 30, 2025, follows their recent Nasdaq uplisting and creates a structural enhancement to their market presence.
Index inclusion brings several tangible benefits: passive funds tracking these benchmarks must purchase shares, typically enhancing trading volume and liquidity. With approximately
Being specifically included in the Russell 2000® positions Solésence in the small-capitalization segment of the market, providing important context on their current market position. Their dual inclusion in both the broad-market Russell 3000® and small-cap Russell 2000® also means automatic categorization in appropriate growth and value style indexes, potentially attracting different investor types.
This market structure improvement aligns with management's strategic vision, as CEO Jess Jankowski emphasized leveraging this milestone to sustain growth momentum in their health care solutions business across beauty and life science categories. While index inclusion doesn't directly impact operational fundamentals, it removes a technical barrier for institutional investment and generally improves a company's capital markets profile.
ROMEOVILLE, Ill., June 24, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it will be added as a member of the broad-market Russell 3000® and small-cap Russell 2000® Indexes, effective after the U.S. market opens on June 30, as part of the 2025 Russell indexes reconstitution.
The annual reconstitution of the Russell US indexes captures the 4,000 largest US stocks as of April 30, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
“Joining both the Russell 3000® and Russell 2000® Indexes is a major achievement for our entire organization,” said Jess Jankowski, President and Chief Executive Officer of Solésence. “This milestone, following our recent uplisting to Nasdaq, significantly enhances our exposure to a wider range of institutional investors. As we continue to invest in developing industry-leading, award-winning skin health solutions, we look forward to leveraging this milestone to help sustain our growth momentum in the years to come.”
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to data as of the end of June 2024, about
For more information on the Russell 3000® Index, the Russell 2000® Index and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website.
About Solésence, Inc.
Solésence, Inc. (Nasdaq: SLSN), is a leader in scientifically-driven health care solutions across beauty and life science categories. With a mission to deliver joy through innovation, inclusivity and the science of beautiful skin, we have redefined mineral-based sun protection by maximizing transparency, effectiveness, aesthetics, and wearability — empowering individuals to embrace beauty on their own terms. Combining best-in-class skin health solutions with the celebration of self-care, we allow brands to deliver unique product claims and attributes by seamlessly integrating protection, prevention, and treatment technologies into daily use products. Learn more at solesence.com.
About FTSE Russell, an LSEG Business
FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering
FTSE Russell is wholly owned by London Stock Exchange Group.
For more information, visit FTSE Russell.
Forward-Looking Statements
This press release contains words such as “expects,” “shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance, and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s engineered materials, ingredients, and fully formulated products; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company’s Form 10-K filed March 31, 2025. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties, or other contingencies.
Media Contact:
media@solesence.com
Investor Relations Contact:
investors@solesence.com
FAQ
When will Solésence (SLSN) join the Russell 3000® and Russell 2000® Indexes?
What is the significance of SLSN joining the Russell indexes?
How are companies selected for the Russell indexes?
What recent milestones has Solésence (SLSN) achieved?
How long will Solésence remain in the Russell 3000® Index?
